Cavalier Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,700	Closed	-$578K	–	179
2018 Q3	$578K	Buy	+4,700	New	+$578K	0.17%	107